Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01901926
Other study ID # Salman-0509
Secondary ID
Status Active, not recruiting
Phase N/A
First received June 12, 2013
Last updated July 15, 2013
Start date December 2012
Est. completion date October 2013

Study information

Verified date July 2013
Source Pakistan Institute of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Pakistan: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effects of non surgical periodontal treatment on glycemic control in type II diabetics.


Description:

The selected patients in treatment group will be given mechanical periodontal treatment in the form of scaling and root planning while the non intervention group patients will not receive treatment until the end of the trial.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 184
Est. completion date October 2013
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- Diagnosed patients of Type 2 Diabetes Mellitus for at least 2 years

- HbA1C values >6.5 % as per ADA criteria

- non smokers

- Patients with at least 16 standing teeth

- At least 8 teeth with one site having Mild to Moderate periodontal disease

Exclusion Criteria:

- Smokers

- Type 2 Diabetics with complications e.g. renal, ophthalmic etc

- Patients with chronic infections

- Patients who get hospitalized or have to change their medications during the course of study

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Non Surgical Periodontal Treatment
one time intervention in the form of scaling and root planing

Locations

Country Name City State
Pakistan Pakistan Institute of Medical Sciences Islamabad Federal Capital

Sponsors (1)

Lead Sponsor Collaborator
Pakistan Institute of Medical Sciences

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Other Fasting Blood Glucose Base Line, 3, 6 and 9 Months No
Other C-Reactive Protein Base Line, 3 months, 6 months, 9 months No
Primary Change in HbA1C levels from base line at 3, 6 and 9 months HbA1C levels will be recorded and any change in percentage noted 3 months, 6 months, 9 months No
Secondary Bleeding on Probing a change in the above mentioned periodontal parameters will be recorded at the specified times Bleeding on probing will be recorded as Yes or No for each tooth Base Line, 3 months, 6 months and 9 months No
Secondary Clinical Attachment Loss A change in the above mentioned periodontal parameter will be recorded at the specified times Clinical Attachment loss will be recorded in millimeters for each tooth Base Line, 3 months, 6 months, 9 months No
Secondary Periodontal Pocket Depth A change in Periodontal pocket will be measured in millimeters for the above mentioned time frame Base Line, 3 months, 6 months, 9 months No
See also
  Status Clinical Trial Phase
Completed NCT01267448 - Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia Phase 4
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Terminated NCT02373865 - Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes Phase 4
Completed NCT01741181 - Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2 Phase 4
Completed NCT01305434 - Mulberry Leaf Extract and Blood Glucose Control in Diabetics Phase 1/Phase 2
Completed NCT01330121 - Bridging the Gap by Transitional Care N/A
Recruiting NCT00992797 - Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity Phase 2
Completed NCT01580904 - Impact of Pharmaceutical Care in Diabetics Patients N/A
Active, not recruiting NCT00728403 - Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes Phase 2
Completed NCT00763815 - GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone Phase 3
Active, not recruiting NCT00529815 - Continuous Glucose Monitoring in Patients With Type 2 Diabetes Phase 4
Completed NCT00517465 - A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus. Phase 1
Completed NCT00119041 - Diabetes Telemedicine Consultation: A Systems Improvement Intervention N/A
Withdrawn NCT00417716 - Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema Phase 3
Withdrawn NCT00600236 - HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population Phase 3
Active, not recruiting NCT05887635 - Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus N/A
Completed NCT03903965 - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Completed NCT02666924 - Cooking Classes for Chinese Canadian Patients Living With Diabetes N/A
Recruiting NCT02501850 - The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) Phase 4